已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Association between PSA density and prostate cancer in men without significant MRI lesions

前列腺癌 医学 肿瘤科 前列腺 内科学 癌症 联想(心理学) 泌尿科 心理学 心理治疗师
作者
Ashkan Mortezavi,Martin Eklund,Martin Bergman,Svein Reidar Kjosavik,Andrea Discacciati,Tobias Nordström
出处
期刊:BJUI [Wiley]
卷期号:125 (6): 763-764 被引量:8
标识
DOI:10.1111/bju.15037
摘要

Dear Editor, The 2019 European guidelines for prostate cancer recommend that biopsy be omitted when multiparametric MRI of the prostate shows no significant (Prostate Imaging Reporting and Data System [PI-RADS] score ≤2) lesions and clinical suspicion of prostate cancer is low; however, it remains unclear how to define 'low clinical suspicion' and one might assume, that clinical suspicion is usually more than low if a costly investigation such as MRI is ordered. The attempt to establish specific parameters in the post-MRI setting adressing this matter is therefore inevitable. In pooled studies on biopsy-naïve patients and patients with prior negative biopsies, it was observed that a Likert/PI-RADS threshold of ≥3 would have missed 11% (95% CI 6–18) of all detected International Society of Urological Pathology (ISUP) grade >2 cancers [1]. In the context of false-negative rates of up to 50% for random systematic biopsies in the pre-MRI era, this missed rate may not sound alarming; however, MRI-invisible prostate cancer (any grade group detected by systematic biopsy) is a frequent clinical finding and its frequency strongly depends on the radiologist's experience, biopsy indication and technique (number of cores). Although a negative MRI is a reassuring result, it poses a challenge for urologists and patients regarding how to proceed. Some research groups have tried to address this issue, but most reports are based on small cohorts because a 'biopsy-all' strategy is no longer the standard of care at most academic centres. While multiparametric prediction models need local recalibration and therefore are often not a practical approach in a clinical setting, PSA density (PSAD) as a single variable has been proposed as a robust and simple predictive tool with which to perform a post-MRI risk assessment [2]. These reports all propose PSAD thresholds based on individual interpretations of what is an acceptable missed cancer rate. This has resulted in the suggested selection of MRI-negative men for biopsy if PSAD exceeds thresholds of between 0.1 and 0.15 ng/mL2 [3-5]. Since there is a wide range of concerns among clinicians regarding the management of these men, presentation of the PSAD behaviour in men with negative MRI results that is fully open to different interpretations seems to be a reasonable approach. We performed an analysis of Scandinavian men from multiple sites referred for prostate cancer diagnostic evaluation. A total of 467 men with no significant lesions on pre-biopsy MRI were included (103 from the prospective, multicentre Stockholm3 phase 1 study [6] and 364 consecutive patients from Stavanger, Norway). All men underwent a biparametric MRI without dynamic contrast. Scans were reported according to the modified PI-RADS (i.e. according to the PI-RADS v.2 guidelines, but with the modification that a PI-RADS 3 lesion in the peripheral zone may not be upgraded to PI-RADS 4), and a PI-RADS grade ≤2 defined no significant lesions. Participants subsequently underwent a transrectal 12-core systematic biopsy. Prostate volume was measured by MRI (0.52*h*w*l) for PSAD calculation. The mean (sd) age was 68 (6.6) years and the mean (sd) PSA value was 6.3 (5.4) ng/mL. The prevalence of ISUP grade group 1, ≥2, ≥3 and ≥4 prostate cancer in this MRI-negative cohort was 19.1% (n = 89), 7.1% (n = 33), 2.6% (n = 12) and 0.9% (n = 4), respectively. The negative predictive value for detection of ISUP grade group ≥2 cancer was 93% (33/467). Using R statistical software v.3.5.3 (R Foundation for Statistical Computing, Vienna, Austria), we plotted cancer detection, proportion of saved biopsies and cancer risk in the biopsied population according to a range of PSAD thresholds (Fig. 1). With this analysis, we describe the potential clinical consequences of using PSAD to select men without significant MRI lesions for prostate biopsy. Our findings are in line with the findings reported by Distler et al. [4] and Washino et al. [5], but provide a greater level of detail for the entire range of relevant PSAD thresholds. Depending on the priorities and concerns of urologists and patients, one can focus on the appropriate graph: the black line, if a missed ISUP grade 2–5 cancer poses a major concern, the red line if overdetection is a major issue, and the yellow line for policy-makers to achieve the desired detection rate in the population addressed by their guideline. Some urologists perform whole-gland treatment in patients with ISUP grade 1 cancer and therefore would strongly recommend systematic biopsies in the context of a negative MRI down to a PSAD of 0.05 ng/mL2, where others would argue for using a higher threshold for omitting biopsies and thus accept a 7% missed rate for ISUP grade ≥2 by referring to the results of the PROTECT trial [7]. However, our data show that a proportion of patients without MRI-visible lesions can be identified as having a non-negligible risk of significant disease, supporting performing prostate biopsies in such men. This is further supported by European Association of Urology guidelines, which recommend a shared decision-making approach. In conclusion, some men without significant MRI lesions have an elevated risk of significant prostate cancer and might be identified using PSAD. The chosen PSAD threshold affects cancer (over)detection, cancer risk in the biopsied population and the number of performed biopsy procedures. None declared.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ccc完成签到 ,获得积分10
刚刚
李爱国的应助被敏于行采纳,获得20
刚刚
Hongtao完成签到 ,获得积分10
1秒前
左岸完成签到 ,获得积分10
2秒前
阿Z完成签到 ,获得积分10
3秒前
就知道吃吃吃完成签到 ,获得积分10
3秒前
Aq完成签到 ,获得积分10
3秒前
3秒前
轩天完成签到,获得积分10
4秒前
大米饭完成签到 ,获得积分10
6秒前
锐锐完成签到 ,获得积分10
6秒前
maplesirup发布了新的文献求助30
7秒前
韦我完成签到 ,获得积分10
8秒前
陈翊完成签到 ,获得积分10
9秒前
10秒前
Lucas的应助被你爱吃鱼吗采纳,获得10
10秒前
科目三的应助被kk采纳,获得10
11秒前
syvshc的应助被kk采纳,获得10
11秒前
期许完成签到,获得积分10
11秒前
reaaa完成签到 ,获得积分10
12秒前
Jerry的应助被shaangu623采纳,获得30
12秒前
琪琪完成签到,获得积分10
12秒前
愉快的朝雪完成签到,获得积分10
12秒前
SheltonYang发布了新的文献求助30
12秒前
13秒前
米线儿完成签到,获得积分10
14秒前
毒药完成签到 ,获得积分10
14秒前
初椿完成签到 ,获得积分10
14秒前
勤奋成威完成签到,获得积分10
14秒前
阳光暖暖的完成签到 ,获得积分10
16秒前
星星完成签到,获得积分10
16秒前
小李完成签到 ,获得积分10
16秒前
哈人发布了新的文献求助10
16秒前
Tao完成签到 ,获得积分10
16秒前
NN的应助被HUANG采纳,获得10
16秒前
希望天下0贩的0的应助被HUANG采纳,获得10
16秒前
mmm完成签到,获得积分20
17秒前
风中的香寒完成签到 ,获得积分10
17秒前
小老屁发布了新的文献求助30
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194810
求助须知:如何正确求助?哪些是违规求助? 9580525
关于积分的说明 21871483
捐赠科研通 7794329
什么是DOI,文献DOI怎么找? 3437718
关于科研通互助平台的介绍 2561095
邀请新用户注册赠送积分活动 2484446